Sort
40,608 grants matching “prostate cancer”
Montana Cancer Consortium
$350,530Montana Cancer Consortium · U10 · FY2004 · CA
The Role of CDK5 in Metastasis
$350,509Barry D. Nelkin · Johns Hopkins University · R01 · FY2010 · CA
The Role of CDK5 in Metastasis
$350,509Barry D. Nelkin · Johns Hopkins University · R01 · FY2008 · CA
The Role of CDK5 in Metastasis
$350,509Barry D. Nelkin · Johns Hopkins University · R01 · FY2009 · CA
Special BD LSR Fortessa
$350,505Manish S Patankar · University Of Wisconsin-Madison · S10 · FY2014 · OD
Cannabinoid CB2 Agonists for Treatment of Breast Cancer Induced Bone Pain
$350,481Todd W Vanderah · University Of Arizona · R01 · FY2017 · CA
Administrative, Leadership Development and Advocacy Core
$350,478Sarki A. Abdulkadir · Northwestern University At Chicago · P50 · FY2024 · CA
Development of peptide antagonists of estrogen signaling
$350,462Duke University · R01 · FY2001 · CA
THE INFLUENCE OF PRIMARY MICROENVIRONMENT ON PROSTATE CANCER OCTEOBLASTIC BONE LESION DEVELOPMENT
$350,452Van Andel Research Institute · · FY2012 · Department of Defense
Enabling Technology to Study Mechanosensitive and Mechanoresistant Cancer Cells in Flow
$350,423Michael R King · Vanderbilt University · R01 · FY2023 · CA
ROLE OF HOMEODOMAIN GENES IN HUMAN PROSTATE CANCER
$350,417University Of Colorado Denver · R01 · FY2002 · CA
Ras-mediated signals in human epithelial cell transformation and metastasis
$350,410Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Nrf2, immune cells and lung cancer
$350,410Karen T. Liby · Michigan State University · R01 · FY2021 · CA
Identifying genetic vulnerabilities in neuroendocrine prostate cancer
$350,381Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
REGULATION OF PCNA FUNCTION BY TYROSINE PHOSPHORYLATION IN PROSTATE CANCER
$350,369Cincinnati Univ Of · · FY2008 · Department of the Army
Pb-212 Peptide Receptor Targeted Prostate Cancer Therapy
$350,330Timothy J. Hoffman · University Of Missouri-Columbia · R01 · FY2021 · CA
Genetically Engineered Viruses for Prostate Cancer Ther
$350,320Robert L Martuza · Massachusetts General Hospital · R01 · FY2006 · CA
Metabolic Syndrome, Fatty Acid Synthesis and Prostate Cancer
$350,303Massimo F Loda · Dana-Farber Cancer Inst · R01 · FY2009 · CA
Metabolic Syndrome, Fatty Acid Synthesis and Prostate Cancer
$350,303Massimo F Loda · Dana-Farber Cancer Inst · R01 · FY2010 · CA
Metabolic Syndrome, Fatty Acid Synthesis and Prostate Cancer
$350,303Massimo F Loda · Dana-Farber Cancer Inst · R01 · FY2008 · CA
Nrf2, immune cells and lung cancer
$350,290Karen T. Liby · Michigan State University · R01 · FY2020 · CA
Translational imaging biomarkers of the tumor microenvironment in early prostate cancer
$350,268Martin G Pomper · Johns Hopkins University · U54 · FY2022 · CA
A metabolic role for PML in tumor suppression
$350,219Pier Paolo Pandolfi · Beth Israel Deaconess Medical Center · R01 · FY2011 · CA
A metabolic role for PML in tumor suppression
$350,219Pier Paolo Pandolfi · Beth Israel Deaconess Medical Center · R01 · FY2012 · CA
Smart nanoparticles regulating oncogenic IncRNA for breast cancer therapy
$350,213Zheng-Rong Lu · Case Western Reserve University · R01 · FY2022 · CA